Zeltiq Aesthetics Inc  

(Public, NASDAQ:ZLTQ)   Watch this stock  
Find more results for ZLTQ
29.90
-0.24 (-0.80%)
Apr 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 29.68 - 30.35
52 week 18.41 - 38.49
Open 29.97
Vol / Avg. 865,578.00/589,213.00
Mkt cap 1.17B
P/E 29.44
Div/yield     -
EPS 1.02
Shares 39.31M
Beta 0.73
Inst. own 120%
Jun 16, 2016
ZELTIQ Aesthetics Inc Annual Shareholders Meeting (Estimated) - 12:00PM EDT - Add to calendar
May 10, 2016
Q1 2016 ZELTIQ Aesthetics Inc Earnings Call - 4:30PM EDT - Add to calendar
May 10, 2016
Q1 2016 ZELTIQ Aesthetics Inc Earnings Release - 4:00PM EDT - Add to calendar
Mar 14, 2016
ZELTIQ Aesthetics Inc at ROTH Conference - Webcast
Feb 29, 2016
Q4 2015 ZELTIQ Aesthetics Inc Earnings Call
Feb 29, 2016
Q4 2015 ZELTIQ Aesthetics Inc Earnings Release
Feb 10, 2016
ZELTIQ Aesthetics Inc at Leerink Partners Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 51.91% 16.37%
Operating margin 2.30% 1.45%
EBITD margin - 2.39%
Return on average assets 104.96% 29.57%
Return on average equity 160.13% 42.91%
Employees 535 -
CDP Score - -

Address

4698 Willow Rd Ste 100
PLEASANTON, CA 94588-2806
United States - Map
+1-925-4742500 (Phone)
+1-925-4742599 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells, which are needed to perform procedures using its CoolSculpting system. As of December 31, 2014, it had an installed base of 3,176 CoolSculpting systems installed across approximately 2,688 practices across the world. As of December 31, 2014, 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Officers and directors

Mark J. Foley President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Taylor C. Harris Chief Financial Officer, Senior Vice President
Age: 40
Bio & Compensation  - Reuters
Keith Sullivan Chief Commercial Officer and President, North America
Age: 57
Bio & Compensation  - Reuters
Sergio Garcia-Rodriguez Senior Vice President, General Counsel and Corporate Secretary
Age: 53
Bio & Compensation  - Reuters
Leonard C. DeBenedictis Chief Technology Officer
Age: 73
Bio & Compensation  - Reuters
Carl H. Lamm Vice President of Operations
Age: 52
Bio & Compensation  - Reuters
David J. Endicott Director
Bio & Compensation  - Reuters
Mary M. Fisher Independent Director
Age: 53
Bio & Compensation  - Reuters
D. Keith Grossman Independent Director
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Independent Director
Age: 60
Bio & Compensation  - Reuters